PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Glycerin of Starch BPC 1963
131500000AABNBN
Generic compound preparation BNF 1315000 Other miscellaneous topical preparations Skin No data available
Glycerin, Blackcurrant swabstick sugar free (old)
120305000AAACAC
Generic compound preparation BNF 1203050 Other treatment of dry mouth preparations Ear, Nose and Oropharynx No data available
Glycerin, Honey and Lemon linctus
0309020H0BJAEAE
Boots glycerol Glycerol Respiratory System No data available
Glycerin, Lemon swabstick sugar free (old)
120305000AAABAB
Generic compound preparation BNF 1203050 Other treatment of dry mouth preparations Ear, Nose and Oropharynx No data available
Glycerol 10% eye drops
1108020L0AAADAD
Glycerol (Eye) Glycerol Eye No data available
Glycerol 10% eye drops preservative free
1108020L0AAANAN
Glycerol (Eye) Glycerol Eye No data available
Glycerol 10% in Cetomacrogol cream (Formula A)
130201000AACZCZ
Generic compound emollients Other emollient preparations Skin No data available
Glycerol 10% wash
130201100AAALAL
Generic compound preparation BNF 1302011 Emollient bath and shower preparations Skin No data available
Glycerol 25% cream
130201000AACLCL
Generic compound emollients Other emollient preparations Skin No data available
Glycerol 66mg / Thymol 880microgram pastilles
1203030V0AAACAC
Thymol (Lozenges/Pastilles) Thymol Ear, Nose and Oropharynx No data available
Glycerol 750mg/5ml oral solution
0309020H0AAAMAM
Glycerol (Expectorant/Demulcents) Glycerol Respiratory System No data available
Glycerol phenylbutyrate 1.1g/ml oral liquid
0908010ATAAAAAA
Glycerol phenylbutyrate Glycerol phenylbutyrate Nutrition and Blood No data available
Glyceryl trinitrate 0.05% ointment
0107040A0AAAKAK
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.1% ointment
0107040A0AAAEAE
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.2% cream
0107040A0AAAYAY
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.2% in White soft paraffin
0107040A0AAAXAX
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.3% in White soft paraffin
0107040A0AAAUAU
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.3% ointment
0107040A0AAACAC
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 0.4% in White soft paraffin
0107040A0AAAVAV
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 1% ointment
0107040A0AAARAR
Glyceryl trinitrate (Haemorrhoids) Glyceryl trinitrate Gastro-Intestinal System No data available
Glyceryl trinitrate 10mg modified-release tablets
0206010F0AAAQAQ
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 10mg/10ml solution for infusion ampoules
0206010F0AACLCL
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 1mg modified-release buccal tablets SF
0206010F0AAAJAJ
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 2.6mg modified-release tablets
0206010F0AAALAL
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 25mg/5ml solution for infusion ampoules
0206010F0AABFBF
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.